Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia (Q46279772)

9 June 2018

title

Effects of Ferric Citrate in Patients with Nondialysis-Dependent CKD and Iron Deficiency Anemia (English)

1 reference

9 June 2018

7

Glenn M Chertow

1 reference

9 June 2018

Geoffrey A. Block

2

object named as

Geoffrey A Block

1 reference

9 June 2018

author name string

Steven Fishbane

1

1 reference

9 June 2018

Lisa Loram

3

1 reference

9 June 2018

John Neylan

4

1 reference

9 June 2018

Pablo E Pergola

5

1 reference

9 June 2018

Katrin Uhlig

6

1 reference

9 June 2018

publication date

12 January 2017

1 reference

9 June 2018

Journal of the American Society of Nephrology

published in

1 reference

9 June 2018

volume

28

1 reference

9 June 2018

issue

6

1 reference

9 June 2018

page(s)

1851-1858

1 reference

9 June 2018

Iron Treatment Strategies in Nondialysis CKD.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Iron Balance and the Role of Hepcidin in Chronic Kidney Disease

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Patient characteristics, disease burden, and medication use in stage 4 - 5 chronic kidney disease patients

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products.

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Ferric citrate controls phosphorus and delivers iron in patients on dialysis.

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Serum fibroblast growth factor-23 is associated with incident kidney disease

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Prevalence of anemia in chronic kidney disease in the United States

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Fibroblast growth factor-23 and cardiovascular events in CKD.

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Mineral metabolites and CKD progression in African Americans

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Effects of phosphate binders in moderate CKD

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

FGF23 induces left ventricular hypertrophy

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

A randomized controlled study of iron supplementation in patients treated with erythropoietin

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Symptoms of iron deficiency anaemia. A community survey.

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Iron management in chronic kidney disease: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference

10 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5461803

A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5

15 August 2018

1 reference

12 December 2020

Correction of uremic iron deficiency anemia in hemodialyzed patients: a prospective study

1 reference

12 December 2020

An evaluation of the effectiveness of oral iron therapy in hemodialysis patients receiving recombinant human erythropoietin

1 reference

12 December 2020

Establishment of a simple test for iron absorption from the gastrointestinal tract

1 reference

12 December 2020

Bone marrow iron, iron indices, and the response to intravenous iron in patients with non-dialysis-dependent CKD

1 reference

12 December 2020

Identifiers

DOI

10.1681/ASN.2016101053

1 reference

9 June 2018

PMC publication ID

5461803

1 reference

9 June 2018

PubMed publication ID

28082519

1 reference

9 June 2018